Adult Wilm’s tumor (Nephroblastoma), with pulmonary and liver metastasis: Case report of a rare tumor and a brief review of the literature

Grace Perez, Leydi Filgueiras, Pedro Novo, Alicia Rojas, Andreas Möck, Manon Djomani, Eseohe Imhansi-Jacob, Kaitlyn Aquino, Jessica Jahoda, Mohammed AzizGSC 2025 · DOI

Abstract

Wilms' tumor (WT), or nephroblastoma, is a common childhood renal neoplasm that is exceptionally rare in adults. While radiological imaging is an excellent diagnostic tool, histomorphologic diagnosis in adults can be challenging due to limited sampling and the rarity of the condition, which often leads to its exclusion from differential diagnoses. We report the case of a 21-year-old woman diagnosed with adult Wilms tumor (AWT) after presenting with a palpable left abdominal mass. Following the Children's Oncology Group (COG) protocol, she underwent a total left nephrectomy. Histology revealed a classic triphasic pattern with blastemal (40%), epithelial (45%), and stromal (15%) components. Despite initial adjuvant chemotherapy, the patient developed pulmonary and liver metastases nine months post-surgery. A more intensive chemotherapy regimen resulted in a favorable response, and the patient remained disease-free at her 26-month follow-up. This case underscores the diagnostic and therapeutic complexities of AWT and the efficacy of pediatric protocols in adult patients.

Introduction

Wilms’ tumor accounts for nearly 90% of pediatric renal cancers but represents less than 1% of adult renal malignancies. Because of this extreme rarity, clinicians often default to a diagnosis of Renal Cell Carcinoma (RCC) when presented with an adult renal mass. AWT presents with symptoms identical to RCC—flank pain, hematuria, and a palpable mass—but requires a vastly different therapeutic approach. Currently, there are no universally accepted treatment guidelines for adults, forcing oncologists to adapt pediatric protocols from the Children's Oncology Group (COG) or the International Society of Pediatric Oncology (SIOP).

Case Presentation and Methods

A 21-year-old female presented with a 13 cm heterogeneous mass in the left kidney, identified via abdominal ultrasound and enhanced CT. Following standard COG protocol, the patient underwent a total left nephrectomy.

Diagnostic techniques employed included:

  • Histopathology: Analysis of the resected tumor to identify the characteristic "triphasic" pattern.
  • Immunohistochemistry (IHC): Markers such as WT1, PAX8, and Vimentin were used to confirm the tumor's renal origin.
  • Molecular Analysis: Next-generation sequencing (NGS) was performed to identify genetic drivers, specifically mutations in the TP53 gene.

Pathological and Molecular Insights

The definitive diagnosis of AWT rests on identifying three distinct histological components: blastemal, epithelial, and stromal. In this case, the tumor exhibited a classic triphasic signature.

Histomorphology of the adult Wilms tumor showing the classic triphasic pattern (A-D).

While the tumor was initially classified as having "favorable histology" (non-anaplastic), molecular profiling revealed a mutation in the TP53 gene (17p13). This genetic marker is often associated with aggressive recurrence and suggests that molecular profiling may provide more accurate prognostic value than morphology alone in adult presentations.

Treatment and Clinical Course

Post-nephrectomy, the patient began adjuvant chemotherapy with Dactinomycin and Doxorubicin. However, nine months later, imaging detected significant tumor burden in the lungs and liver. Due to the extent of the metastases, surgical intervention was not feasible. The clinical team pivoted to a triple-drug pediatric regimen consisting of Vincristine, Dactinomycin, and Doxorubicin.

Summary of the patient's clinical timeline from presentation to last follow-up.

This intensive salvage therapy proved highly effective. The patient achieved a complete clinical response and remained disease-free for 26 months following the initiation of the second-line treatment.

Discussion and Conclusion

This case highlights the critical need for including AWT in the differential diagnosis of adult renal masses. The successful outcome demonstrates that pediatric chemotherapy protocols can be highly effective in adults, even in the presence of heavy metastatic disease.

Future management of AWT should likely incorporate routine Next-Generation Sequencing (NGS) to identify high-risk markers like TP53, WT1, and IGF2 early in the diagnostic process. Furthermore, the development of age-stratified protocols is necessary to address the more aggressive biology often observed in adult patients. Although this patient was lost to follow-up after 26 months, her initial recovery provides a strong argument for the use of intensive multi-agent chemotherapy in treating recurrent adult nephroblastoma.

Summary updated

Abstract

Wilms' tumor (WT) (nephroblastoma) is a childhood renal neoplasm encountered rarely in adults. Although radiological imaging is an excellent tool for diagnosis in most cases, histomorphologic diagnosis can be challenging, especially with limited sampling, which may result in the potential absence of one of the three histological components. In addition, the rare occurrence in adults makes it less likely to be included in the differential diagnosis of an adult presenting with a renal mass. We report a case of a 21-year-old woman who presented with a left abdominal palpable mass, eventually diagnosed with an adult Wilms tumor (AWT). Following the Children's Oncology Group (COG) protocol, the patient underwent total left nephrectomy. The histological features were classic triphasic, with blastemal (40%), epithelial (45%), and stromal (15%) components, and occasional foci of anaplasia, which were not sufficient to classify it as an anaplastic subtype. The patient had adjuvant chemotherapy with Dactinomycin and Doxorubicin and initially responded well to treatment. Nine months after nephrectomy, pulmonary and liver metastases were found. Surgical treatment was not possible due to the high tumor burden in the lung and the liver. Chemotherapy, including Vincristine, Dactinomycin, and Doxorubicin, was initiated, resulting in a favorable clinical response. The patient was disease-free at the last follow-up, 26 months after treatment. This case highlights the diagnostic and therapeutic challenges associated with AWTs. We provide a brief review of the literature, including history, clinical presentation, diagnosis, and treatment. We also discuss the potential benefits of diagnosing and treating AWTs with current technological advancements.
BibTeX
@inproceedings{perez2025adult,
  author = {Grace Perez and Leydi Filgueiras and Pedro Novo and Alicia Rojas and Andreas Möck and Manon Djomani and Eseohe Imhansi-Jacob and Kaitlyn Aquino and Jessica Jahoda and Mohammed Aziz},
  title = {{Adult Wilm’s tumor (Nephroblastoma), with pulmonary and liver metastasis: Case report of a rare tumor and a brief review of the literature}},
  booktitle = {GSC},
  year = {2025},
  doi = {10.30574/gscarr.2025.24.1.0199},
}
Figure